Serum HDAC3 as an Early Indicator for Predicting and Staging Acute Kidney Injury Associated with Sepsis: A Prospective Cohort Analysis - Summary - MDSpire
Advertisement
Serum HDAC3 as an Early Indicator for Predicting and Staging Acute Kidney Injury Associated with Sepsis: A Prospective Cohort Analysis
To measure serum HDAC3 levels in patients with sepsis and evaluate its predictive capacity for the onset of SA-AKI within seven days.
Key Findings:
Over 40% of sepsis patients develop AKI, with high mortality rates.
Traditional markers like serum creatinine are insufficient for early AKI detection.
HDAC3 levels may serve as a sensitive biomarker for early identification of SA-AKI.
Interpretation:
Serum HDAC3 could be a valuable early biomarker for predicting SA-AKI in sepsis patients, potentially improving clinical outcomes through timely intervention.
Limitations:
Single-centre study may limit generalizability.
Exclusion of patients with chronic kidney disease may affect findings.
Conclusion:
Serum HDAC3 levels may provide an early indicator for SA-AKI in sepsis, warranting further investigation for clinical application.
